Hai Zhu, MD, Ph.D
Chief Physician
Master Instructor
Director of the Department of Urology
Qingdao Municipal Hospital
http://qdslyy.cn/zhuanjia-view.aspx?id=1029
Education
Ph.D., Qingdao University, Qingdao, China, 2011
Visiting Scholar, St. Vincent's Hospital, Melbourne, Australia, 2001
M.S., Qingdao University, Qingdao, China, 2000
B.S., Qingdao University, Qingdao, China, 1993
Expertise and Research Interests
Engaged in urology for more than 20 years, he has unique insights into the diagnosis and treatment of difficult and complicated cases of the urinary system. Skilled in surgical treatment of male genitourinary system tumors, stones, prostate diseases, deformities and plastics. Served as the Vice Chairman of Qingdao Urology Department of Chinese Medical Association, Leader of Qingdao Bladder Cancer Group, Vice Chairman of Qingdao Andrology Department, Vice Chairman of Shandong Andrology Youth Vice Chairman, Member of Shandong Medical Association (Urology Department), and member of the Committee of Integrated Traditional Chinese and Western Medicine Urology Surgery. Rated as the outstanding medical expert in Qingdao in 2015.
Committed to research on andrology related diseases such as prostate disease, male sexual dysfunction, male infertility, etc.
Awards
1. The second prize of Qingdao Science and Technology Progress Award, J2013-2-51-1, Troglitazone's anti-prostate cancer cell growth and invasion mechanism, 2014/02, first place.
2. The second prize of Shandong Province Science and Technology Progress Award, JB2013-2-125-R04, the discovery, secretion regulation and clinical significance of thyroid motilin, 2014/02, fourth place.
3. Second prize of Qingdao Science and Technology Natural Science, Z2013-2-5-4, Motilin discovery and its related peptide Ghrelin biological effects and clinical significance, 2014/02, fourth place.
Selected Publications (* co-first author # co-corresponding author)
1. L. Shen*, X. Song*, Y. Xu, R. Tian, Y. Wang, P. Li, J. Li, H. Bai, H. Zhu#, D. Wang#, Patterned vascularization in a directional ice-templated scaffold of decellularized matrix. Engineering in Life Sciences, 2021:1–10.
2. H. Zhao, H. Dong, P. Wang, H. Zhu, Long non‑coding RNA SNHG17 enhances the aggressiveness of C4‑2 human prostate cancer cells in association with β‑catenin signaling. Oncology Letters 2021, 21: 472
3. H. Zhu, B. Han, X. Pan, H. Qi, L. Xu, Thiazolidenediones induce tumour-cell apoptosis through the Akt-GSK3β pathway, Journal of Clinical Pharmacy and Therapeutics 2012, 37 (1): 65-70
4. H. Zhu, X. Pan, H. Qi, X. Wang, S. Hou, B. Han, Z. Liu, L. Xu, Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells, Oncology Reports, 2011, 25 (1): 81-90
